 |
The following persons contributed to the NTWG documents:
Francis André, (CHAIRMAN) Rixensart, Belgium
Subgroup 1: Stabilization
Debra Kristensen, Team Leader, Immunization Technologies, PATH (Seattle)
Mogens Munck, c/o UNICEF, Kabul, Afghanistan
Peter Carrasco, Technical Officer, HVP/HVI, WHO Regional Office, AMRO
Subgroup 2: Non-invasive test
Neil Constantine, Professor of Pathology, Director, Clinical Immunology, University of Maryland, USA
Aldo Tagliabue, Deputy Director for Laboratory Sciences, International Vaccine Institute
Shillim-Dong, Kwanak-Ku, Seoul, Korea
Pat Cricenti, Chief, GHDB, FDA/CDRH/ODE/DDIGD
Subgroup 3:Defanging
Bruce Weniger, Assistant Chief for Vaccine Development, CDC, Atlanta, USA
Souleymane Kone, WHO, Côte d'Ivoire
Mogens Munck, UNICEF, Kabul, Afghanistan
Chairpersons:
Professor Myron Mike Levine
Director, Center for Vaccine Development,University of Maryland, USA
Dr Rino Rappuoli
Head of Research, Chiron, Italy
Dr Marie-Paule Kieny
Director, Initiative for Vaccine Research, WHO, Switzerland
Secretariat:
Dr. Teresa Aguado, Coordinator, Initiative for Vaccine Research, WHO, Switzerland
Assisted by Dr. Makda Fisseha and Dr. Martin Friede (Initiative for Vaccine Research)
R&D Task Force Core Members:
Dr Elaine Esber
Executive Director, lnternational Medical Affairs
Professor Jan Holmgren, University of Göteborg, Sweden
Dr Rosanna Lagos, Hospital Roberto del Rio, Chili
Sir Dr Gustav J.V. Nossal, Professor Emeritus, The University of Melbourne, Australia
Dr Punnee Pitisuttithum, Chief of Clinical Infectious Diseases Research Unit Mahidol University, Thailand
Dr Fred Binka, University of Ghana, Ghana
|
|
|
|
Resources
New Technology Working Group
New
Summary Report (PDF, 57K)
New
Full Report (PDF, 618K)
Members
Related documents
25 June 2003 Working Group teleconference
full text
7th GAVI Board meeting
Read the original discusion of the various technologies
|
|